Adenovirus vector for immunogene therapy of liver cell carcinoma (lcc)
The invention regards the use of viral or adenoviral vectors for selective tumour thera-peutic methods of liver cell carcinoma in the form of an immunogene therapy.
Further Information: PDF
PVA Mecklenburg-Vorpommern AG
Phone: +49 (0)381/49 74 74 0
Contact
Antonio Martinez
Media Contact
All latest news from the category: Technology Offerings
Newest articles
First-of-its-kind study uses remote sensing to monitor plastic debris in rivers and lakes
Remote sensing creates a cost-effective solution to monitoring plastic pollution. A first-of-its-kind study from researchers at the University of Minnesota Twin Cities shows how remote sensing can help monitor and…
Laser-based artificial neuron mimics nerve cell functions at lightning speed
With a processing speed a billion times faster than nature, chip-based laser neuron could help advance AI tasks such as pattern recognition and sequence prediction. Researchers have developed a laser-based…
Optimising the processing of plastic waste
Just one look in the yellow bin reveals a colourful jumble of different types of plastic. However, the purer and more uniform plastic waste is, the easier it is to…